Skip to main content
https://pbs.twimg.com/media/Fhh29a0WQAI5ATY.jpg
Tuttle et al. Phase 2 RCT of Peresolimab (PD-1 stimulator) in DMARD-IR RA. Evidence of efficacy. No new safety signals @RheumNow #ACR22 Abstr#L03 https://t.co/vhrmtGTjw1 https://t.co/k1LLk95bv1
Richard Conway
14-11-2022
×